Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects
Yangyang Lin,Sam Z Grinter,Zhongju Lu,Xianjin Xu,Hong Zhan Wang,Hongwu Liang,Panpan Hou,Junyuan Gao,Chris Clausen,Jingyi Shi,Wenshan Zhao,Zhiwei Ma,Yongfeng Liu,Kelli McFarland White,Lu Zhao,Po Wei Kang,Guohui Zhang,Ira S Cohen,Xiaoqin Zou,Jianmin Cui
DOI: https://doi.org/10.1073/pnas.2024215118
2021-05-18
Abstract:Cardiac arrhythmias are the most common cause of sudden cardiac death worldwide. Lengthening the ventricular action potential duration (APD), either congenitally or via pathologic or pharmacologic means, predisposes to a life-threatening ventricular arrhythmia, Torsade de Pointes. IKs (KCNQ1+KCNE1), a slowly activating K+ current, plays a role in action potential repolarization. In this study, we screened a chemical library in silico by docking compounds to the voltage-sensing domain (VSD) of the IKs channel. Here, we show that C28 specifically shifted IKs VSD activation in ventricle to more negative voltages and reversed the drug-induced lengthening of APD. At the same dosage, C28 did not cause significant changes of the normal APD in either ventricle or atrium. This study provides evidence in support of a computational prediction of IKs VSD activation as a potential therapeutic approach for all forms of APD prolongation. This outcome could expand the therapeutic efficacy of a myriad of currently approved drugs that may trigger arrhythmias.